Skip to main content
Log in

Anti-inflammatory effect of the alpha-melanocyte stimulating hormonein animal eyes undergoing extracapsular lens extraction

  • Cell Molecular Biology
  • Published:
Molecular Biology Aims and scope Submit manuscript

Abstract

In this study anti-inflammatory effects of the alpha-melanocyte stimulating hormone (α-MSH) on ocular inflammation caused by extracapsular lens extraction (ECLE) have been investigated and the potential mechanism of an anti-inflammatory effect is discussed. Pigmented rabbit eyes after ECLE were treated locally with α-MSH, dexamethasone, diclofenac, or saline 4 times a day (q.i.d.) for 4 weeks. The inhibitory effect of α-MSH on infiltrating cells in the aqueous humor (AqH) was almost twice as good as that of dexamethasone or diclofenac for 3 days, 1 week, and 2 weeks after the operation. The eyes of Sprague-Dawley rats were treated with an intravenous injection of α-MSH or saline immediately after ECLE. Six hours postoperatively, the iris/ciliary body exhibited increased expression of TNF-α and IL-6 mRNAs, which were significantly decreased after α-MSH treatment. The number of activated NF-kappa B (NFκB)-positive cells in the iris/ciliary body was also significantly reduced by the α-MSH treatment. These results suggested that α-MSH could effectively reduce ocular inflammation after ECLE, and the potential mechanism for this is by down-regulating the expression of proinflammatory cytokines and inhibiting the NFκB-dependent signaling pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AC:

anterior chamber

AqH:

aqueous humor

ECLE:

extracapsular lens extraction

ICB:

iris/ciliary body

IOP:

intraocular pressure

α-MSH:

α-melanocyte stimulating hormone

q.i.d.:

4 times a day (from the Latin “quater in die”)

t.i.d:

3 times a day

References

  1. Alberts B., Bray D., Lewis J., et al. 1994. Molecular Biology of the Cell, 3rd ed. N.Y.: Garland Publ.

    Google Scholar 

  2. Rajora N., Ceriani G., Catania A., et al. 1996. α-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line. J. Leukoc. Biol. 59, 248–253.

    PubMed  CAS  Google Scholar 

  3. Lugar T.A., Scholzen T., Grabbe S. 1997. The role of alpha-melanocyte stimulating hormone in cutaneous biology. J. Invest. Dermatol. 2, 87–93.

    Google Scholar 

  4. Smith A.I., Funder J.W. 1988. Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr. Rev. 9, 159–179.

    Article  PubMed  CAS  Google Scholar 

  5. Marx J. 1991. How peptide hormones get ready for work. Science. 252(5007), 779–780.

    Article  PubMed  CAS  Google Scholar 

  6. Rajora N., Boccoli G., Burns D., et al. 1997. Alpha-MSH modulates local and circulating tumor necrosis factor-alpha in experimental brain inflammation. J. Neurosci. 17, 2181–2186.

    PubMed  CAS  Google Scholar 

  7. Chiao H., Foster S., Thomas R., et al. 1996. Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. J. Clin. Invest. 97, 2038–2044.

    Article  PubMed  CAS  Google Scholar 

  8. Chiao H., Kohda Y., McLeroy P., et al. 1997. Alpha melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J. Clin. Invest. 99, 1165–1172.

    Article  PubMed  CAS  Google Scholar 

  9. Ceriani G., Macaluso A., Catania A., et al. 1994. Central neurogenic anti-inflammatory action of alpha-MSH: Modulation of peripheral inflammation induced by cytokines and other mediators of inflammation. Neuroendocrinology. 59, 138–143.

    Article  PubMed  CAS  Google Scholar 

  10. Robertson B.A., Dostal K., Daynes R.A. 1988. Neuropeptide regulation of inflammatory and immunologic responses. The capacity of alpha-melano-cytestimulating hormone to inhibit tumor necrosis factor and IL-1-inducible biologic responses. J. Immunol. 140, 4300–4307.

    PubMed  CAS  Google Scholar 

  11. Chiao H., Foster S., Thomas R., et al. 1996. Alpha-Melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. J. Clin. Invest. 97, 2038–2044.

    Article  PubMed  CAS  Google Scholar 

  12. Catania A., Rajora N., Capsoni F., et al. 1996. The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides. 17, 675–679.

    Article  PubMed  CAS  Google Scholar 

  13. Star R.A., Rajora N., Huang J., et al. 1995. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. U.S.A. 92, 8016–8020.

    Article  PubMed  CAS  Google Scholar 

  14. Rajora N., Boccoli G., Catania A., et al. 1997. Alpha-MSH modulates experimental inflammatory bowel disease. Peptides. 18, 381–385.

    Article  PubMed  CAS  Google Scholar 

  15. Daynes R.A., Robertson B.A., Cho B.-H., et al. 1987. Alpha-melanocyte-stimulating hormone exhibits target cell selectivity in its capacity to affect interleukin 1-inducible responses in vivo and in vitro. J. Immunol. 139, 103–109.

    PubMed  CAS  Google Scholar 

  16. Dyster-Aas H.K., Krakau C.E.T. 1965. General effects of alpha-melanocyte stimulating hormone in the rabbit. Acta Endocrinol. 48, 609–618.

    PubMed  CAS  Google Scholar 

  17. Hernandez D.E., Simons K.B., Spampinato D., et al. 1985. Intracameral administration of alpha-MSH increases intraocular pressure in rabbits. Neuropeptides. 6, 553–559.

    Article  PubMed  CAS  Google Scholar 

  18. Hiltz M.E., Lipton J.M. 1990. Alpha-MSH peptides inhibit acute inflammation and contact sensitivity. Peptides. 11, 979–982.

    Article  PubMed  CAS  Google Scholar 

  19. Ostrov C.S, Sirkin S.R., Deutsch W.E., et al. 1997. Ketorolac, prednisolone, and dexamethasone for postoperative inflammation. Clin. Ther. 19, 259–272.

    Article  PubMed  CAS  Google Scholar 

  20. McCullen R.K., Peiffer R.L., Jennes L., et al. 1988. Inhibition by MIF-I of alpha-MSH induced increase of intraocular pressure and miosis in rabbits. Neuropeptides. 12, 213–217.

    Article  PubMed  CAS  Google Scholar 

  21. Williams R.N., Paterson C.A. 1984. Polymorphonuclear accumulation in aqueous humor and iris-ciliary body during intraocular inflammation. Invest. Ophthalmol. Vis Sci. 25, 105–108.

    PubMed  CAS  Google Scholar 

  22. Goodall T., Buffey J.A., Rennie I.G., et al. 1994. Effect of melanocyte stimulating hormone on human cultured choroidal melanocytes, uveal melanoma cells, and retinal epithelial cells. Invest. Ophthalmol. Vis. Sci. 35, 826–837.

    PubMed  CAS  Google Scholar 

  23. Naveh N., Marshall J. 2001. Melanocortins are comparable to corticosteroids as inhibitors of traumatic ocular inflammation in rabbits. Graefes Arch. Clin. Exp. Ophthalmol. 239, 840–844.

    Article  PubMed  CAS  Google Scholar 

  24. Bauer B., Ehinger B. 1980. Action of alpha-MSH on the release of neurotransmitters from the retina. Acta Physiol. Scand. 108, 105–107.

    Article  PubMed  CAS  Google Scholar 

  25. Holmdahl G., Bengtsson E. 1981. The effect of timolol maleate on the disruption of the blood-aqueous barrier in the rabbit eye. Invest. Ophthalmol. Vis. Sci. 20, 726–732.

    PubMed  CAS  Google Scholar 

  26. Lois N., Dawson R., McKinnon A.D., et al. 2003. A new model of posterior capsule opacification in rodents. Invest. Ophthalmol. Vis. Sci. 44, 3450–3457.

    Article  PubMed  Google Scholar 

  27. Shiratori K., Ohgami K., Ilieva I.B., et al. 2004. Inhibition of endotoxin-induced uveitis and potentiation of cyclooxygenase-2 protein expression by alpha-melanocyte-stimulating hormone. Invest. Ophthalmol. Vis. Sci. 45, 159–164.

    Article  PubMed  Google Scholar 

  28. Alio J.L., Sayans J.A, Chipont E., et al. 1997. Flare-cell meter measurement of inflammation after uneventful cataract surgery with intraocular lens implantation. J. Cataract. Refract. Surg. 23, 935–939.

    PubMed  CAS  Google Scholar 

  29. Sawa M. 1990. Clinical application of laser flare-cell meter. Jpn. J. Ophthalmol. 34(3), 346–363.

    PubMed  CAS  Google Scholar 

  30. el-Maghraby A., Marzouki A., Matheen T.M., et al. 1992. Reproducibility and validity of laser flare/cell meter measurements as an objective method of assessing intraocular inflammation. Arch. Ophthalmol. 110, 960–962.

    PubMed  CAS  Google Scholar 

  31. el-Maghraby A., Marzouki A., Matheen T.M., et al. 1993. Reproducibility and validity of laser flare/cell meter measurements of intraocular inflammation. J. Cataract. Refract. Surg. 19, 52–55.

    PubMed  CAS  Google Scholar 

  32. Knepper P.A., Collins J.A., Frederick R. 1985. Effects of dexamethasone, progesterone, and testosterone on IOP and GAGs in the rabbit eye. Invest. Ophthalmol. Vis. Sci. 26, 1093–1100.

    PubMed  CAS  Google Scholar 

  33. Dyster-Aas H.K., Krakau C.E.T. 1963. A photo-electric instrument for measuring the aqueous flare in the intact eye. Ophthalmologica. 146, 48–56.

    Article  PubMed  CAS  Google Scholar 

  34. Dyster-Aas H.K., Krakau C.E. T. 1965. General effects of alpha-melanocyte stimulating hormone in the rabbit. Acta Endocrinol. 48, 609–618.

    PubMed  CAS  Google Scholar 

  35. Dyster-Aas K., Krakau C.E.T. 1964. Increased permeability of the blood-aqueous humor barrier in the rabbit’s eye provoked by melanocyte stimulating peptides. Endocrinology. 74, 255–265.

    Article  PubMed  CAS  Google Scholar 

  36. Naveh N., Kaplan-Messas A., Marshall J. 2000. Mechanism related to reduction of intraocular pressure by melanocortins in rabbits. Br. J. Ophthalmol. 84, 1411–1414.

    Article  PubMed  CAS  Google Scholar 

  37. Abdel-Malek Z.A., Swope V.B., Trinkle L.S., et al. 1989. Stimulation of Cloudman melanoma tyrosinase activity occurs predominantly in G2 phase of the cell cycle. Exp. Cell. Res. 180, 198–208.

    Article  PubMed  CAS  Google Scholar 

  38. Neufeld A.H., Jampol L.M., Sears M.L. 1972. Aspirin prevents the disruption of the blood-aqueous barrier in the rabbit eye. Nature. 238, 158–159.

    Article  PubMed  CAS  Google Scholar 

  39. Crosson C.E. 1995. Adenosine receptor activation modulates intraocular pressure in rabbits. J. Pharmacol. Exp. Ther. 273, 320–326.

    PubMed  CAS  Google Scholar 

  40. Yousufzai S.Y., Zheng P., Abdel-Latif A.A. 1994. Muscarinic stimulation of arachidonic acid release and prostaglandin synthesis in bovine ciliary muscle, prostaglandins induce cyclic AMP formation and muscle relaxation. Exp. Eye Res. 58, 513–522.

    Article  PubMed  CAS  Google Scholar 

  41. Hyatt P.J., Bell J.B.G., Bhatt K., et al. 1986. Effect of alphamelanocyte-stimulating-hormone on the cyclic AMP and phospholipid metabolism of rat adrenocortical cells. J. Endocrinol. 110, 405–416.

    Article  PubMed  CAS  Google Scholar 

  42. Bar-Ilan A., Savion N., Naveh N., et al. 1992. Alpha-melanocyte stimulating hormone (alpha-MSH) enhances eicosanoid production by bovine retinal pigment epithelium. Prostaglandins. 43, 31–44..

    Article  PubMed  CAS  Google Scholar 

  43. Serle J.B., Podos S.M., Kitazawa Y., et al. 1998. A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes. Jpn. J. Ophthalmol. 42, 95–100.

    Article  PubMed  CAS  Google Scholar 

  44. Hoekzema R., Verhagen C., van Haren M., Kijlstra A. 1992. Endotoxininduced uveitis in the rat: the significance of intraocular interleukin-6. Invest. Ophthalmol. Vis. Sci. 33, 532–539.

    PubMed  CAS  Google Scholar 

  45. de Vos A.F., van Haren M.A.C., Verhagen C., Hoekzema R., Kijlstra A. 1994. Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxininduced uveitis in the rat. Invest. Ophthalmol. Vis. Sci. 35, 1100–1106.

    PubMed  Google Scholar 

  46. Haddad J.J., Land S.C., Tarnow-Mordi W.O., Zembala M., Kowalczyk D., Lauterbach R. 2002. Immunopharmacological potential of selective phosphodiesterase inhibition. Differential regulation of lipopolysaccharide-mediated proinflammatory cytokine (interleukin-6 and tumor necrosis factor-α) biosynthesis in alveolar epithelial cells. J. Pharmacol. Exp. Ther. 300, 559–566.

    Article  PubMed  CAS  Google Scholar 

  47. Lang C.H., Silvis C., Deshpande N., Nystrom G., Frost R.A. 2003. Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, Interleukin-1β-6, and high-mobility group protein-1 in skeletal muscle. Shock. 19, 538–546.

    Article  PubMed  CAS  Google Scholar 

  48. Zhou Z., He S., Cheng X. 1996. An experimental study of tumor necrosis factor (TNF) and interleukin-1 (IL-1) in aqueous humor after intraocular lens implantation. Zhonghua Yan Ke Za Zhi. 32, 301–303.

    PubMed  CAS  Google Scholar 

  49. Er H., Gunduz A., Turkoz Y., et al. 1999. Effects of NG-nitro L-arginine and corticosteroids on aqueous humor levels of nitric oxide and cytokines after cataract surgery. J. Cataract. Refract. Surg. 25, 795–799.

    Article  PubMed  CAS  Google Scholar 

  50. Zhaohui Z., Shouzhi H. 1999. An experimental study of the tumour necrosis factor levels in aqueous humor after traumatic cataract and intraocular lens implantation. Chin. Med. Sci. J. 14, 64–66.

    PubMed  CAS  Google Scholar 

  51. Qi M.X., Huang X.R., Shen S.R., et al. 2003. A study on cytokine levels and nitric oxide content in rabbit aqueous humor after lens extraction and intraocular lens implantation. Zhonghua Yan Ke Za Zhi. 39, 41–43.

    PubMed  Google Scholar 

  52. Taherzadeh S., Sharma S., Chhajlani V., et al. 1999. Alpha-MSH and its receptors in regulation of tumor necrosis factor-alpha production by human monocyte/macrophages. Am. J. Physiol. 276, 1289–1294.

    Google Scholar 

  53. Adachi S., Nakano T., Vliagoftis H., et al. 1999. Receptor-mediated modulation of murine mast cell function by alpha-melanocyte stimulating hormone. J. Immunol. 163, 3363–3368.

    PubMed  CAS  Google Scholar 

  54. Luger T.A., Brzoska T., Scholzen T.E., et al. 2000. The role of alpha-MSH as a modulator of cutaneous inflammation. Ann. N.Y. Acad. Sci. 917, 232–238.

    Article  PubMed  CAS  Google Scholar 

  55. Luger T.A., Scholzen T.E., Brzoska T., et al. 2003. New insights into the functions of alpha-MSH and related peptides in the immune system. Ann. N.Y. Acad. Sci. 994, 133–140.

    Article  PubMed  CAS  Google Scholar 

  56. Chi Z.L., Hayasaka S., Zhang X.Y., et al. 2004. Effects of rolipram, a selective inhibitor of type 4 phosphodiesterase, on lipopolysaccharide-induced uveitis in rats. Invest. Ophthalmol. Vis. Sci. 45, 2497–2502.

    Article  PubMed  Google Scholar 

  57. Parry G.C., Mackman N. 1994. A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers. J. Biol. Chem. 269, 20823–20831.

    PubMed  CAS  Google Scholar 

  58. Schmitz M.L., Stelzer G., Altmann H., et al. 1995. Interaction of the COOH-terminal transactivation domain of p65 NF-kappa B with TATA-binding protein, transcription factor II kappa NB, and coactivators. J. Biol. Chem. 270, 7219–7226.

    Article  PubMed  CAS  Google Scholar 

  59. Baeuerle P.A., Henkel T. 1994. Function and activation of NF-kappa B in the immune system. Annu, Rev. Immunol. 12, 141–179.

    Article  CAS  Google Scholar 

  60. Baldwin A.S., Jr. 1996. The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu. Rev. Immunol. 14, 649–683.

    Article  PubMed  CAS  Google Scholar 

  61. May M.J., Ghosh S. 1998. Signal transduction through NF-kappa B. Immunol. Today. 9, 80–88.

    Article  Google Scholar 

  62. Wang L., Walia B., Evans J., et al. 2003. IL-6 induces NF-kappa B activation in the intestinal epithelia. J. Immunol. 171, 3194–3201.

    PubMed  CAS  Google Scholar 

  63. Nishida T., Miyata S., Itoh Y., et al. 2004. Anti-inflammatory effects of alpha-melanocyte-stimulating hormone against rat endotoxin-induced uveitis and the time course of inflammatory agents in aqueous humor. Int. Immunopharmacol. 4(8), 1059–1066.

    Article  PubMed  CAS  Google Scholar 

  64. Hamrah P., Haskova Z., Taylor A.W., Zhang Q., Ksander B.R., Dana M.R. 2009. Local treatment with alpha-melanocyte stimulating hormone reduces corneal allorejection. Transplantation. 88(2), 180–187.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ke Yao.

Additional information

The article is published in the original.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, Z., Yao, K., Ma, J. et al. Anti-inflammatory effect of the alpha-melanocyte stimulating hormonein animal eyes undergoing extracapsular lens extraction. Mol Biol 45, 241–250 (2011). https://doi.org/10.1134/S002689331006107X

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S002689331006107X

Keywords

Navigation